By Counterforce Health Team in Pombiliti (cipaglucosidase alfa-atga) —

How to Get Pombiliti (cipaglucosidase alfa-atga) Covered by UnitedHealthcare in Florida: Complete Prior Authorization and Appeals Guide

Answer Box: To get Pombiliti (cipaglucosidase alfa-atga) covered by UnitedHealthcare in Florida, you'll need prior authorization with documented failure on current ERT (step therapy). Submit via UHCprovider.com or OptumRx forms (fax 844-403-1027). Include late-onset Pompe diagnosis, enzyme/genetic testing, and prior therapy outcomes. If denied, appeal within 180 days internally, then request Florida external review through DFS at 877-693-5236. Start by verifying your plan type and downloading the correct PA form today.

Table of Contents

Verify Your Plan and Find the Right Forms

Before starting your Pombiliti prior authorization, identify your specific UnitedHealthcare plan type. This determines which forms and submission pathways you'll use.

Plan Types and Forms:

Plan Type Forms Location Submission Method Key Differences
Commercial/Medicare with OptumRx UnitedHealthcare-OptumRx PA Form Fax: 844-403-1027
Portal: UHCprovider.com		 Standard step therapy applies
Community Plan (Medicaid) FL Community Plan forms UHC Provider Portal Plan-specific PA criteria
WellMed Medicare Advantage eprg.wellmed.net WellMed Provider Gateway Separate submission system
Tip: Check the back of your insurance card for "OptumRx" or look for Payer ID "WELM2" to identify the correct pathway.

Prior Authorization Requirements

UnitedHealthcare requires prior authorization for Pombiliti with specific step therapy requirements for late-onset Pompe disease.

Coverage Criteria at a Glance

Requirement What You Need Where to Document
Diagnosis Late-onset Pompe disease confirmed ICD-10 code + enzyme/genetic testing
Age/Weight ≥40 kg body weight Clinical notes
Step Therapy Not improving on current ERT 6MWT decline or functional measures
Combination Must pair with Opfolda (miglustat) Separate PA required
Specialist Neurologist or metabolic specialist Prescriber attestation

Medical Necessity Criteria:

  • GAA enzyme deficiency (<40% in lymphocytes/fibroblasts) OR biallelic pathogenic GAA gene variants
  • Clinical symptoms: muscle weakness, respiratory involvement, or functional decline
  • Documented lack of improvement on prior ERT (Lumizyme or Nexviazyme)
  • Patient weight ≥40 kg (adult indication only)

Submission Portals and Methods

Primary Submission: UnitedHealthcare Provider Portal

  1. Access: UHCprovider.com (register with One Healthcare ID if needed)
  2. Navigate: Prior Authorization and Notification tool
  3. Upload: Clinical documentation directly through portal
  4. Track: Real-time status updates available 24/7

Alternative: Electronic PA

  • CoverMyMeds: Select OptumRx and specific UHC plan for automated routing
  • EDI 278 transactions: Available through UHCprovider.com/EDI

Fax Submission

  • Non-urgent: 844-403-1027 (OptumRx)
  • Urgent/expedited: Call 800-711-4555 first, then fax
  • Cover sheet: Include member ID, prescriber NPI, and "POMBILITI PA REQUEST"

Clinical Documentation Checklist

Required Documents

  • Diagnosis confirmation: Enzyme assay results and/or genetic testing report
  • Prior ERT history: Drug names, dates, duration, and response measures
  • Functional assessments: 6-minute walk test, pulmonary function tests, or muscle strength
  • Treatment failure documentation: Objective evidence of decline or lack of improvement
  • Prescriber letter: Medical necessity justification with clinical rationale

Clinician Corner: Medical Necessity Letter Components

Your letter should address:

  1. Problem statement: Late-onset Pompe disease diagnosis with specific symptoms
  2. Prior treatments: Complete ERT history with outcomes and reasons for change
  3. Clinical rationale: Why Pombiliti is medically necessary vs. alternatives
  4. Monitoring plan: How you'll assess treatment response
  5. Supporting evidence: FDA labeling, clinical guidelines, or peer-reviewed studies

Key citations to reference:

Common Denial Reasons and Solutions

Denial Reason How to Overturn Required Documentation
No step therapy documentation Provide detailed prior ERT history Treatment timeline with outcomes
Insufficient diagnosis evidence Submit complete enzyme/genetic testing Lab reports with reference ranges
Missing specialist involvement Get neurologist or geneticist attestation Specialist consultation note
Concurrent ERT use Confirm discontinuation of prior therapy Treatment stop date documentation
Weight requirement not met Document patient weight ≥40 kg Recent clinic visit notes
From our advocates: "We've seen Pombiliti denials overturned most successfully when the appeal includes a detailed timeline showing functional decline on prior ERT, paired with the specialist's letter explaining why the combination therapy is the next appropriate step. This composite approach addresses both the step therapy requirement and medical necessity criteria in one comprehensive package."

Appeals Process in Florida

Internal Appeals (Required First Step)

Timeline: 180 days from denial notice to file Process:

  1. Submit written appeal to UnitedHealthcare
  2. Include all supporting clinical documentation
  3. Reference specific policy sections and coverage criteria
  4. Request peer-to-peer review if available

Submission methods:

  • Online: UHC Provider Portal or member portal
  • Fax: Number provided in denial letter
  • Mail: Address specified in denial notice

External Review (After Internal Appeal)

If your internal appeal is denied, Florida law provides external review rights.

Florida Department of Financial Services:

External Review Process:

  1. File complaint with DFS within 4 months of final internal denial
  2. DFS coordinates independent medical review
  3. External reviewer decision is binding on UnitedHealthcare
  4. No cost to consumer for external review

Expedited Review: Available for urgent medical situations (72-hour decision timeline)

Specialty Pharmacy Network

Pombiliti requires specialty pharmacy dispensing due to its limited distribution and infusion requirements.

UnitedHealthcare Contracted Specialty Pharmacies in Florida

  • Accredo: 800-803-2523, accredo.com
  • OptumRx Specialty (formerly BriovaRx): 866-218-7398
  • AllianceRx Walgreens Prime: Network partner for specialty medications
  • Optum Infusion: 877-306-4036 for provider-administered therapies

Pharmacy Onboarding Steps

  1. Verify network status: Confirm pharmacy participates with your specific plan
  2. Transfer prescription: Provide current pharmacy and prescription details
  3. Insurance verification: Pharmacy will verify PA approval and benefits
  4. Delivery coordination: Arrange home delivery or clinic shipment
  5. Patient education: Specialty pharmacy provides injection training and support

Counterforce Health helps patients navigate these complex specialty pharmacy requirements by coordinating between providers, payers, and pharmacies to ensure smooth medication access.

Support Resources

Patient Support

  • UnitedHealthcare Member Services: Number on back of insurance card
  • Amicus Assist: Manufacturer patient support program
  • Pompe disease organizations: National and local advocacy groups

Provider Support

  • UHC Provider Services: Available through provider portal
  • OptumRx PA line: 800-711-4555 for urgent requests
  • Clinical consultation: Peer-to-peer review requests

Florida Insurance Assistance

  • Florida Department of Financial Services: 877-693-5236
  • Consumer assistance: Free mediation and complaint resolution
  • Insurance Consumer Advocate: Systemic issues and policy concerns

FAQ

How long does UnitedHealthcare PA take in Florida? Standard PA decisions are typically made within 15 business days. Expedited reviews for urgent cases are processed within 72 hours.

What if Pombiliti is non-formulary on my plan? Non-formulary medications can still be covered through the PA process with strong medical necessity documentation. Focus on demonstrating lack of formulary alternatives.

Can I request expedited appeal if I'm already on therapy? Yes, if discontinuing Pombiliti would pose immediate health risks, you can request expedited internal and external review simultaneously.

Does step therapy apply if I failed ERT outside Florida? Prior therapy documentation from any location is valid. Provide complete medical records showing ERT trial and outcomes.

What happens if my appeal is denied? After exhausting UnitedHealthcare's internal appeals, you have the right to external review through Florida DFS. This independent medical review is binding on the insurer.

How much does Pombiliti cost without insurance? List price is approximately $650,000 annually for the Pombiliti + Opfolda combination. Manufacturer assistance programs may be available for eligible patients.

Can my doctor do a peer-to-peer review? Yes, most PA denials allow for physician-to-physician discussion. Request this through the UHC provider line or portal.

What if I need Pombiliti for off-label use? Pombiliti is only FDA-approved for late-onset Pompe disease in adults ≥40 kg. Off-label requests require extensive clinical justification and are less likely to be approved.

This guide provides educational information and should not replace professional medical or legal advice. Coverage decisions depend on individual plan terms and clinical circumstances. For personalized assistance with complex prior authorization challenges, consider consulting with specialists like Counterforce Health, who help turn insurance denials into successful, evidence-backed appeals.

Sources & Further Reading

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.